ACTIVELLA Side Effects

6858685-6 | Breast Cancer
on May 08, 2009 Female patient from UNITED STATES , 64 years of age, weighting 164.9 lb, was diagnosed with hot flush and was treated with Activella (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). Activella dosage: , Oral. During the same period patient was treated with PREMPRO (, Oral) (View Prempro Review and Prempro Label ), ESTRATEST (View Estratest Review and Estratest Label ), PROVERA (, Oral) (View Provera Review and Provera Label ), PREMARIN (, Oral) (View Premarin Review and Premarin Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ).

6858617-0 | Breast Cancer
Patient was taking Activella (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?) on May 08, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 250.0 lb, . Activella dosage: , Oral. During the same period patient was treated with PREMARIN (, Oral) (View Premarin Review and Premarin Label ), PREMPRO (, Oral) (View Prempro Review and Prempro Label ), ESTRACE (View Estrace Review and Estrace Label ), ORTHO PREFEST (ESTRADIOL, NORGESTIMATE) (View Ortho-prefest (estradiol, Norgestimate) Review and Ortho-prefest (estradiol, Norgestimate) Label ), PROVERA (View Provera Review and Provera Label ).

6858541-3 | Breast Cancer
Adverse event was reported on May 08, 2009 by a Female patient taking Activella (View Usage) (Dosage: Oral) was diagnosed with menopause (What is menopause?) and. Location: UNITED STATES , 54 years of age, weighting 130.1 lb, After Activella was administered, patient had the following side effects: breast cancer (What is breast cancer?). During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PREMPRO (View Prempro Review and Prempro Label ), PROVERA (View Provera Review and Provera Label ).

6858424-9 | Breast Cancer
on May 08, 2009 Female patient from UNITED STATES , 69 years of age, weighting 119.9 lb, was treated with Activella (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). Activella dosage: Oral. During the same period patient was treated with ESTROPIPATE (Oral) (View Estropipate Review and Estropipate Label ), PREMPRO (View Prempro Review and Prempro Label ), PREMARIN (View Premarin Review and Premarin Label ), ACTINOL (PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE, TRIPROLIDINE HYDR (View Actinol (paracetamol, Pseudoephedrine Hydrochloride, Triprolidine Hydr Review and Actinol (paracetamol, Pseudoephedrine Hydrochloride, Triprolidine Hydr Label ).


6858367-0 | Breast Cancer
on May 08, 2009 Female patient from UNITED STATES , 69 years of age, weighting 115.1 lb, was diagnosed with hot flush, menopausal symptoms and was treated with Activella (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?). Activella dosage: Oral. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PREMPRO (View Prempro Review and Prempro Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ACTONEL (View Actonel Review and Actonel Label ).

6858118-X | Breast Cancer Metastatic
Patient was taking Activella (View Usage). After Activella was administered, patient had the following side effects: breast cancer metastatic on May 08, 2009 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 155.0 lb, . Activella dosage: , Oral. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PREMPRO (0.625, Oral) (View Prempro Review and Prempro Label ), PREMPHASE (PREMARIN;CYCRIN 14/14) (View Premphase (premarin;cycrin 14/14) Review and Premphase (premarin;cycrin 14/14) Label ), PROVERA (View Provera Review and Provera Label ), CELEBREX (View Celebrex Review and Celebrex Label ).

6858035-5 | Breast Cancer Stage I
Adverse event was reported on Aug 11, 2009 by a Female patient taking Activella (View Usage) (Dosage: Oral) was diagnosed with menopausal symptoms and. Location: UNITED STATES , 57 years of age, weighting 183.0 lb, Patient experienced the following unwanted or unexpected effects: breast cancer stage i. During the same period patient was treated with ESTRACE (1-2 Mg, Oral) (View Estrace Review and Estrace Label ), PREMPRO (0.625 Mg/2.5 Mg, Oral) (View Prempro Review and Prempro Label ), ORTHO PREFEST (ESTRADIOL, NORGESTIMATE) (, Oral) (View Ortho-prefest (estradiol, Norgestimate) Review and Ortho-prefest (estradiol, Norgestimate) Label ), MEDROXYPROGESTERONE (2.5 Mg, Oral) (View Medroxyprogesterone Review and Medroxyprogesterone Label ), PROVERA (5 ; 2.5 Mg, Oral) (View Provera Review and Provera Label ), CYCRIN (2.5 Mg, Oral) (View Cycrin Review and Cycrin Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6858034-3 | Breast Cancer
on Apr 27, 2009 Female patient from UNITED STATES , 64 years of age, weighting 190.0 lb, was treated with Activella (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?). Activella dosage: , Oral. During the same period patient was treated with PREMPRO (0.625mg/5mg, Oral) (View Prempro Review and Prempro Label ), PREMPHASE (PREMARIN;CYCRIN 14/14) (0.625mg/5mg, Oral) (View Premphase (premarin;cycrin 14/14) Review and Premphase (premarin;cycrin 14/14) Label ), PROVERA (5 Mg, Oral) (View Provera Review and Provera Label ), ESTRATAB (0.625 Mg, Oral) (View Estratab Review and Estratab Label ), ORTHO PREFEST (ESTRADIOL, NORGESTIMATE) (1mg/0.09mg) (View Ortho-prefest (estradiol, Norgestimate) Review and Ortho-prefest (estradiol, Norgestimate) Label ), ORTHO NOVUM 0.5/50 21 TAB (View Ortho Novum 0.5/50 21 Tab Review and Ortho Novum 0.5/50 21 Tab Label ), COZAAR (View Cozaar Review and Cozaar Label ).

6858033-1 | Breast Cancer
on May 08, 2009 Female patient from UNITED STATES , 56 years of age, weighting 151.9 lb, was treated with Activella (View Usage). After Activella was administered, patient had the following side effects: breast cancer (What is breast cancer?). Activella dosage: . During the same period patient was treated with MEDROXYPROGESTERONE ACETATE (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), PROMETRIUM (View Prometrium Review and Prometrium Label ), ESTRATAB (View Estratab Review and Estratab Label ), ORTHO PREFEST (ESTRADIOL, NORGESTIMATE) (View Ortho-prefest (estradiol, Norgestimate) Review and Ortho-prefest (estradiol, Norgestimate) Label ), CELEBREX (View Celebrex Review and Celebrex Label ), PREVACID (View Prevacid Review and Prevacid Label ), PROTONIX (View Protonix Review and Protonix Label ), ACTONEL (View Actonel Review and Actonel Label ).

6858032-X | Arthritis, Breast Cancer
Patient was taking Activella (View Usage). Patient experienced the following unwanted or unexpected effects: arthritis (What is arthritis?), breast cancer (What is breast cancer?) on Nov 12, 2009 from UNITED STATES Additional patient health information: Female patient , 62 years of age, weighting 115.1 lb, . Activella dosage: 1mg/.5mg. During the same period patient was treated with CYCRIN (2.5 ; 2.5 Mg) (View Cycrin Review and Cycrin Label ), PROVERA (2.5 Mg) (View Provera Review and Provera Label ), MEDROXYPROGESTERONE ACETATE (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), PREMPRO (0.625mg/2.5mg ; 0.45mg/1.5mg) (View Prempro Review and Prempro Label ), PREMARIN (0.625 Mg) (View Premarin Review and Premarin Label ), ESTRACE (0.1 Mg/gm Cream) (View Estrace Review and Estrace Label ). Patient was hospitalized.

6858028-8 | Breast Cancer
Adverse event was reported on May 08, 2009 by a Female patient taking Activella (View Usage) (Dosage: Oral) . Location: UNITED STATES , 54 years of age, weighting 157.0 lb, Patient had the following side effects: breast cancer (What is breast cancer?). During the same period patient was treated with PREMPRO (Oral) (View Prempro Review and Prempro Label ), FEMHRT (Oral) (View Femhrt Review and Femhrt Label ), TRIAMTERENE (TRIAMTERENE) (View Triamterene (triamterene) Review and Triamterene (triamterene) Label ).

6858027-6 | Breast Cancer
on Jan 12, 2010 Female patient from UNITED STATES , 55 years of age, was treated with Activella (View Usage). After Activella was administered, patient had the following side effects: breast cancer (What is breast cancer?). Activella dosage: Oral. During the same period patient was treated with PREMPRO (Oral) (View Prempro Review and Prempro Label ).

6858026-4 | Breast Cancer
on Jan 19, 2010 Female patient from UNITED STATES , 64 years of age, was treated with Activella (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). Activella dosage: Oral. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), ESTROPIPATE (View Estropipate Review and Estropipate Label ), PREMPHASE (PREMARIN;CYCRIN 14/14) (View Premphase (premarin;cycrin 14/14) Review and Premphase (premarin;cycrin 14/14) Label ), FEMHRT (View Femhrt Review and Femhrt Label ), OGEN (View Ogen Review and Ogen Label ).

6858025-2 | Breast Cancer, Scleroderma
Patient was taking Activella (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?), scleroderma (What is scleroderma?) on Aug 19, 2009 from UNITED STATES Additional patient health information: Female patient , 60 years of age, weighting 119.0 lb, was diagnosed with menopause (What is menopause?) and. Activella dosage: 1 Mg (.5mg). During the same period patient was treated with PREMARIN (1.25 Mg) (View Premarin Review and Premarin Label ), PROVERA (10 Mg On Days 16 Through 25) (View Provera Review and Provera Label ), ESTROPIPATE (1.5 Mg, (1.25mg)) (View Estropipate Review and Estropipate Label ), MEDROXYPROGESTERONE (10 Mg Days 16 Through 25) (View Medroxyprogesterone Review and Medroxyprogesterone Label ), CYCRIN (10 Mg, Qd On Days 16 Through 25) (View Cycrin Review and Cycrin Label ).

6858024-0 | Breast Cancer
Adverse event was reported on Aug 19, 2009 by a Female patient taking Activella (View Usage) (Dosage: 1 Tab, Qd, Oral) was diagnosed with hot flush and. Location: UNITED STATES , 63 years of age, weighting 130.1 lb, After Activella was administered, patient had the following side effects: breast cancer (What is breast cancer?). During the same period patient was treated with PREMPRO (2.5 Mg, Oral ; 5 Mg) (View Prempro Review and Prempro Label ), COMBIPATCH (50/250, Transdermal ; 50/140 ; 50/250, Transdermal) (View Combipatch Review and Combipatch Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

6858023-9 | Breast Cancer
on Apr 27, 2009 Female patient from UNITED STATES , 53 years of age, weighting 112.0 lb, was treated with Activella (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). Activella dosage: 1 Mg/ 0.5mg, Oral. During the same period patient was treated with PREMPRO (0.625/2.5 Mg, Oral ; 0.45/1.5 Mg, Oral) (View Prempro Review and Prempro Label ), CRESTOR (View Crestor Review and Crestor Label ), RECLAST (View Reclast Review and Reclast Label ), CALTRATE + D (CALCIUM CARBONATE, COLECALCIFEROL) (View Caltrate + D (calcium Carbonate, Colecalciferol) Review and Caltrate + D (calcium Carbonate, Colecalciferol) Label ).

6858021-5 | Breast Cancer In Situ
on Apr 06, 2009 Female patient from UNITED STATES , 69 years of age, weighting 112.0 lb, was treated with Activella (View Usage). Patient had the following side effects: breast cancer in situ. Activella dosage: 0.05 Mg. During the same period patient was treated with PROVERA (2.5 Mg, Oral) (View Provera Review and Provera Label ), OGEN (0.625 Mg) (View Ogen Review and Ogen Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), ETHINYL ESTRADIOL TAB (View Ethinyl Estradiol Tab Review and Ethinyl Estradiol Tab Label ), THYROLAR (LEVOTHYROXINE SODIUM, LIOTHYRONINE SODIUM) (View Thyrolar (levothyroxine Sodium, Liothyronine Sodium) Review and Thyrolar (levothyroxine Sodium, Liothyronine Sodium) Label ), CALAN (View Calan Review and Calan Label ), ACTONEL (View Actonel Review and Actonel Label ).

6858019-7 | Breast Cancer
Patient was taking Activella (View Usage). After Activella was administered, patient had the following side effects: breast cancer (What is breast cancer?) on Jul 29, 2009 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 170.0 lb, was diagnosed with hot flush and. Activella dosage: Oral. During the same period patient was treated with PREMPRO (0.625/2.5 Mg, Oral) (View Prempro Review and Prempro Label ), COMBIPATCH (, Transdermal) (View Combipatch Review and Combipatch Label ), CLIMARA PRO (, Transdermal) (View Climara Pro Review and Climara Pro Label ), PLAVIX (View Plavix Review and Plavix Label ), PREVACID (View Prevacid Review and Prevacid Label ). Patient was hospitalized.

6748460-5 | Arthritis, Breast Cancer
Adverse event was reported on Nov 12, 2009 by a Female patient taking Activella (View Usage) (Dosage: 1mg/.5mg) . Location: UNITED STATES , 62 years of age, weighting 115.1 lb, Patient experienced the following unwanted or unexpected effects: arthritis (What is arthritis?), breast cancer (What is breast cancer?). During the same period patient was treated with CYCRIN (2.5 ; 2.5 Mg) (View Cycrin Review and Cycrin Label ), PROVERA (2.5 Mg) (View Provera Review and Provera Label ), MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ), PREMPRO (0.625mg/2.5mg ; 0.45mg/1.5mg) (View Prempro Review and Prempro Label ), PREMARIN (0.625 Mg) (View Premarin Review and Premarin Label ), ESTRACE (0.1 Mg/gm Cream) (View Estrace Review and Estrace Label ). Patient was hospitalized.

6748458-7 | Breast Cancer
on May 08, 2009 Female patient from UNITED STATES , 69 years of age, weighting 130.1 lb, was diagnosed with menopausal symptoms and was treated with Activella (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?). Activella dosage: Oral. During the same period patient was treated with PREMPRO (Oral) (View Prempro Review and Prempro Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6748454-X | Arthritis, Heart Rate Increased
on Apr 02, 2009 Female patient from UNITED STATES , 60 years of age, was diagnosed with hot flush, menorrhagia and was treated with Activella (View Usage). After Activella was administered, patient had the following side effects: arthritis (What is arthritis?), heart rate increased. Activella dosage: Oral. During the same period patient was treated with WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), MAXZIDE (View Maxzide Review and Maxzide Label ), TENORMIN (View Tenormin Review and Tenormin Label ), TRIAMCINE (TRIAMCINOLONE ACETATE) (View Triamcine (triamcinolone Acetate) Review and Triamcine (triamcinolone Acetate) Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

6748451-4 | Breast Cancer, Scleroderma
Patient was taking Activella (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?), scleroderma (What is scleroderma?) on Aug 19, 2009 from UNITED STATES Additional patient health information: Female patient , 60 years of age, weighting 119.0 lb, was diagnosed with menopause (What is menopause?) and. Activella dosage: 1 Mg(.5mg). During the same period patient was treated with PREMARIN (1.25 Mg) (View Premarin Review and Premarin Label ), PROVERA (10 Gm On Days 16 Through 25) (View Provera Review and Provera Label ), ESTROPIPATE (1.5 Mg, (1.25mg)) (View Estropipate Review and Estropipate Label ), MEDROXYPROGESTERONE (10 Mg Days 16 Through 25) (View Medroxyprogesterone Review and Medroxyprogesterone Label ), CYCRIN (10 Mg, Qd On Days 16 Through 25) (View Cycrin Review and Cycrin Label ).

6748449-6 | Breast Cancer
Adverse event was reported on Aug 19, 2009 by a Female patient taking Activella (View Usage) (Dosage: 1 Tab, Qd, Oral) was diagnosed with hot flush and. Location: UNITED STATES , 63 years of age, weighting 130.1 lb, Patient had the following side effects: breast cancer (What is breast cancer?). During the same period patient was treated with PREMPRO (2.5 Mg, Oral ; 5 Mg) (View Prempro Review and Prempro Label ), COMBIPATCH (50/250, Transdermal ; 50/140 ; 50/250, Transdermal) (View Combipatch Review and Combipatch Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

6748448-4 | Breast Cancer
on Apr 27, 2009 Female patient from UNITED STATES , 53 years of age, weighting 112.0 lb, was treated with Activella (View Usage). After Activella was administered, patient had the following side effects: breast cancer (What is breast cancer?). Activella dosage: 1mg/0.5mg, Oral. During the same period patient was treated with PREMPRO (0.625/2.5 Mg, Oral ; 0.45/1.5 Mg, Oral) (View Prempro Review and Prempro Label ), CRESTOR (View Crestor Review and Crestor Label ), RECLAST (View Reclast Review and Reclast Label ), CALTRATE + D /00944201/ (CALCIUM CARBONATE, COLECALCIFEROL) (View Caltrate + D /00944201/ (calcium Carbonate, Colecalciferol) Review and Caltrate + D /00944201/ (calcium Carbonate, Colecalciferol) Label ).

6748445-9 | Breast Cancer In Situ
on Apr 06, 2009 Female patient from UNITED STATES , 69 years of age, weighting 112.0 lb, was treated with Activella (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer in situ. Activella dosage: Reported As 0.05 Mg. During the same period patient was treated with PROVERA (2.5 Mg, Oral) (View Provera Review and Provera Label ), OGEN (0.625 Mg) (View Ogen Review and Ogen Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), ETHINYL ESTRADIOL TAB (View Ethinyl Estradiol Tab Review and Ethinyl Estradiol Tab Label ), THYROLAR (LEVOTHYROXINE SODIUM, LIOTHYRONINE SODIUM) (View Thyrolar (levothyroxine Sodium, Liothyronine Sodium) Review and Thyrolar (levothyroxine Sodium, Liothyronine Sodium) Label ), CALAN /00014302/ (VERAPAMIL HYDROCHLORIDE) (View Calan /00014302/ (verapamil Hydrochloride) Review and Calan /00014302/ (verapamil Hydrochloride) Label ), ACTONEL (View Actonel Review and Actonel Label ).

6748442-3 | Breast Cancer
Patient was taking Activella (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?) on Jul 29, 2009 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 170.0 lb, was diagnosed with hot flush and. Activella dosage: Oral. During the same period patient was treated with PREMPRO (0.625/2.5 Mg, Oral) (View Prempro Review and Prempro Label ), COMBIPATCH (Transdermal) (View Combipatch Review and Combipatch Label ), CLIMARA PRO (Transdermal) (View Climara Pro Review and Climara Pro Label ), PLAVIX (View Plavix Review and Plavix Label ), PREVACID (View Prevacid Review and Prevacid Label ). Patient was hospitalized.

6748441-1 | Breast Cancer
Adverse event was reported on May 08, 2009 by a Female patient taking Activella (View Usage) (Dosage: Oral) was diagnosed with hot flush and. Location: UNITED STATES , 64 years of age, weighting 164.9 lb, After Activella was administered, patient had the following side effects: breast cancer (What is breast cancer?). During the same period patient was treated with PREMPRO (Oral) (View Prempro Review and Prempro Label ), ESTRATEST (View Estratest Review and Estratest Label ), PROVERA (Oral) (View Provera Review and Provera Label ), PREMARIN (Oral) (View Premarin Review and Premarin Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ).

6748439-3 | Breast Cancer
on May 08, 2009 Female patient from UNITED STATES , weighting 250.0 lb, was treated with Activella (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). Activella dosage: Oral. During the same period patient was treated with PREMARIN (Oral) (View Premarin Review and Premarin Label ), PREMPRO (Oral) (View Prempro Review and Prempro Label ), ESTRACE (View Estrace Review and Estrace Label ), ORTHO PREFEST (ESTRADIOL, NORGESTIMATE) (View Ortho-prefest (estradiol, Norgestimate) Review and Ortho-prefest (estradiol, Norgestimate) Label ), PROVERA (View Provera Review and Provera Label ).

6748438-1 | Breast Cancer
on May 08, 2009 Female patient from UNITED STATES , 54 years of age, weighting 130.1 lb, was diagnosed with menopause (What is menopause?) and was treated with Activella (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?). Activella dosage: Oral. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PREMPRO (View Prempro Review and Prempro Label ), PROVERA (View Provera Review and Provera Label ).

6748435-6 | Breast Cancer
Patient was taking Activella (View Usage). After Activella was administered, patient had the following side effects: breast cancer (What is breast cancer?) on May 08, 2009 from UNITED STATES Additional patient health information: Female patient , 69 years of age, weighting 119.9 lb, . Activella dosage: Oral. During the same period patient was treated with ESTROPIPATE (Oral) (View Estropipate Review and Estropipate Label ), PREMPRO (View Prempro Review and Prempro Label ), PREMARIN (View Premarin Review and Premarin Label ), ACTINOL (PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE, TRIPROLIDINE HYDR (View Actinol (paracetamol, Pseudoephedrine Hydrochloride, Triprolidine Hydr Review and Actinol (paracetamol, Pseudoephedrine Hydrochloride, Triprolidine Hydr Label ).

6748433-2 | Breast Cancer
Adverse event was reported on May 08, 2009 by a Female patient taking Activella (View Usage) (Dosage: Oral) was diagnosed with hot flush, menopausal symptoms and. Location: UNITED STATES , 69 years of age, weighting 115.1 lb, Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PREMPRO (View Prempro Review and Prempro Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ACTONEL (View Actonel Review and Actonel Label ).

6748431-9 | Breast Cancer Metastatic
on May 08, 2009 Female patient from UNITED STATES , 57 years of age, weighting 155.0 lb, was treated with Activella (View Usage). Patient had the following side effects: breast cancer metastatic. Activella dosage: Oral. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PREMPRO (0.625, Oral) (View Prempro Review and Prempro Label ), PREMPHASE (PREMARIN;CYCRIN 14/14) (View Premphase (premarin;cycrin 14/14) Review and Premphase (premarin;cycrin 14/14) Label ), PROVERA (View Provera Review and Provera Label ), CELEBREX (View Celebrex Review and Celebrex Label ).

6748428-9 | Breast Cancer Stage I
on Aug 11, 2009 Female patient from UNITED STATES , 57 years of age, weighting 183.0 lb, was diagnosed with menopausal symptoms and was treated with Activella (View Usage). After Activella was administered, patient had the following side effects: breast cancer stage i. Activella dosage: Oral. During the same period patient was treated with ESTRACE (1-2 Mg, Oral) (View Estrace Review and Estrace Label ), PREMPRO (0.625 Mg/2.5 Mg, Oral) (View Prempro Review and Prempro Label ), ORTHO PREFEST (ESTRADIOL, NORGESTIMATE) (Oral) (View Ortho-prefest (estradiol, Norgestimate) Review and Ortho-prefest (estradiol, Norgestimate) Label ), MEDROXYPROGESTERONE (2.5 Mg, Oral) (View Medroxyprogesterone Review and Medroxyprogesterone Label ), PROVERA (5 ; 2.5 Mg, Oral) (View Provera Review and Provera Label ), CYCRIN (2.5 Mg, Oral) (View Cycrin Review and Cycrin Label ), NORVASC /00972401/ (AMLODIPINE) (View Norvasc /00972401/ (amlodipine) Review and Norvasc /00972401/ (amlodipine) Label ). Patient was hospitalized.

6748423-X | Breast Cancer
Patient was taking Activella (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?) on Apr 27, 2009 from UNITED STATES Additional patient health information: Female patient , 64 years of age, weighting 190.0 lb, . Activella dosage: Oral. During the same period patient was treated with PREMPRO (0.625mg/5mg, Oral) (View Prempro Review and Prempro Label ), PREMPHASE (PREMARIN;CYCRIN 14/14) (0.625mg/5mg, Oral) (View Premphase (premarin;cycrin 14/14) Review and Premphase (premarin;cycrin 14/14) Label ), PROVERA (5 Mg, Oral) (View Provera Review and Provera Label ), ESTRATAB (0.625 Mg, Oral) (View Estratab Review and Estratab Label ), ORTHO PREFEST (ESTRADIOL, NORGESTIMATE) (1mg/0.09mg) (View Ortho-prefest (estradiol, Norgestimate) Review and Ortho-prefest (estradiol, Norgestimate) Label ), ORTHO NOVUM 0.5/50 21 TAB (View Ortho Novum 0.5/50 21 Tab Review and Ortho Novum 0.5/50 21 Tab Label ), COZAAR (View Cozaar Review and Cozaar Label ).

6748421-6 | Breast Cancer
Adverse event was reported on May 08, 2009 by a Female patient taking Activella (View Usage) (Dosage: ) . Location: UNITED STATES , 56 years of age, weighting 151.9 lb, Patient had the following side effects: breast cancer (What is breast cancer?). During the same period patient was treated with MEDROXYPROGESTERONE ACETATE (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), PROMETRIUM (View Prometrium Review and Prometrium Label ), ESTRATAB (View Estratab Review and Estratab Label ), ORTHO PREFEST (ESTRADIOL, NORGESTIMATE) (View Ortho-prefest (estradiol, Norgestimate) Review and Ortho-prefest (estradiol, Norgestimate) Label ), CELEBREX (View Celebrex Review and Celebrex Label ), PREVACID (View Prevacid Review and Prevacid Label ), PROTONIX (View Protonix Review and Protonix Label ), ACTONEL (View Actonel Review and Actonel Label ).

6728277-8 | Breast Cancer
on May 07, 2010 Female patient from UNITED STATES , weighting 160.0 lb, was diagnosed with hot flush, night sweats, depression (What is depression?), pain (What is pain?), back pain (What is back pain?) and was treated with Activella (View Usage). After Activella was administered, patient had the following side effects: breast cancer (What is breast cancer?). Activella dosage: . During the same period patient was treated with PROZAC /00724402/ (View Prozac /00724402/ Review and Prozac /00724402/ Label ), HYDROCODIN /00060002/ (View Hydrocodin /00060002/ Review and Hydrocodin /00060002/ Label ), CODEINE SULFATE (View Codeine Sulfate Review and Codeine Sulfate Label ).

6544316-1 | Alopecia
on Jan 20, 2010 Female patient from UNITED STATES , 50 years of age, weighting 125.0 lb, was diagnosed with menopause (What is menopause?) and was treated with Activella (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia. Activella dosage: 1 Tablet Per Day Po.

6376787-8 | Insomnia
Patient was taking Activella (View Usage). Patient had the following side effects: insomnia on Sep 24, 2009 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 158.0 lb, . Activella dosage: .

6371759-1 | Tooth Infection
Adverse event was reported on Sep 15, 2009 by a Female patient taking Activella (View Usage) (Dosage: 1 Tab, Qd) was diagnosed with menopause (What is menopause?) and. Location: UNITED STATES , 60 years of age, After Activella was administered, patient had the following side effects: tooth infection.

6215182-9 | Breast Cancer
on Jul 21, 2008 Female patient from UNITED STATES , 47 years of age, was diagnosed with menopausal symptoms and was treated with Activella (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). Activella dosage: Oral. During the same period patient was treated with PREMARIN (Oral) (View Premarin Review and Premarin Label ), PREMPRO (Oral) (View Prempro Review and Prempro Label ).

6215180-5 | Breast Cancer
on May 08, 2009 Female patient from UNITED STATES , weighting 250.0 lb, was treated with Activella (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?). Activella dosage: Oral. During the same period patient was treated with PREMARIN (Oral) (View Premarin Review and Premarin Label ), PREMPRO (Oral) (View Prempro Review and Prempro Label ), ESTRACE (View Estrace Review and Estrace Label ), ORTHO PREFEST (ESTRADIOL, NORGESTIMATE) (View Ortho-prefest (estradiol, Norgestimate) Review and Ortho-prefest (estradiol, Norgestimate) Label ), PROVERA (View Provera Review and Provera Label ).

6215178-7 | Breast Cancer
Patient was taking Activella (View Usage). After Activella was administered, patient had the following side effects: breast cancer (What is breast cancer?) on Oct 31, 2008 from UNITED STATES Additional patient health information: Female patient , 65 years of age, . Activella dosage: Oral. During the same period patient was treated with PROVERA (View Provera Review and Provera Label ), PREMPRO (View Prempro Review and Prempro Label ), PREMARIN (View Premarin Review and Premarin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), NORMADIL (NIFEDIPINE) (View Normadil (nifedipine) Review and Normadil (nifedipine) Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ALBUTEROL /00139501/ (SALBUTAMOL) (View Albuterol /00139501/ (salbutamol) Review and Albuterol /00139501/ (salbutamol) Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6215177-5 | Breast Cancer
Adverse event was reported on Oct 31, 2008 by a Female patient taking Activella (View Usage) (Dosage: 1 Tab) was diagnosed with menstruation irregular and. Location: UNITED STATES , 56 years of age, weighting 125.0 lb, Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). During the same period patient was treated with PREMARIN (1.25 Mg) (View Premarin Review and Premarin Label ), MEDROXYPROGESTERONE ACETATE (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), LOESTRIN 1.5/30 (1/20, Oral) (View Loestrin 1.5/30 Review and Loestrin 1.5/30 Label ). Patient was hospitalized.

6215174-X | Breast Cancer
on Oct 31, 2008 Female patient from UNITED STATES , 52 years of age, weighting 151.9 lb, was diagnosed with uterine haemorrhage, menopausal symptoms and was treated with Activella (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?). Activella dosage: . During the same period patient was treated with PROVERA (View Provera Review and Provera Label ), PREMPRO (0.625/2,5mg) (View Prempro Review and Prempro Label ), ORTHO PREFEST(ESTRADIOL, NORGESTIMATE) (View Ortho-prefest(estradiol, Norgestimate) Review and Ortho-prefest(estradiol, Norgestimate) Label ), FEMHRT (View Femhrt Review and Femhrt Label ), NORVASC /00972401/ (AMLODIPINE) (View Norvasc /00972401/ (amlodipine) Review and Norvasc /00972401/ (amlodipine) Label ), VYTORIN (View Vytorin Review and Vytorin Label ). Patient was hospitalized.

6215173-8 | Breast Cancer
on Oct 31, 2008 Female patient from UNITED STATES , 67 years of age, weighting 145.9 lb, was treated with Activella (View Usage). After Activella was administered, patient had the following side effects: breast cancer (What is breast cancer?). Activella dosage: Oral. During the same period patient was treated with PREMARIN (Oral) (View Premarin Review and Premarin Label ), CYCRIN (View Cycrin Review and Cycrin Label ), PREMPRO (2.5 Mg, Oral) (View Prempro Review and Prempro Label ), PROVERA (Oral) (View Provera Review and Provera Label ), TRIAVIL (AMITRIPTYLINE HYDROCHLORIDE) (View Triavil (amitriptyline Hydrochloride) Review and Triavil (amitriptyline Hydrochloride) Label ), FOSAMAX (ALANDRONATE SODIUM) (View Fosamax (alandronate Sodium) Review and Fosamax (alandronate Sodium) Label ), CELEBREX (View Celebrex Review and Celebrex Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ).

6215168-4 | Breast Cancer
Patient was taking Activella (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?) on Oct 31, 2008 from UNITED STATES Additional patient health information: Female patient , 53 years of age, weighting 134.9 lb, was diagnosed with menopausal symptoms and. Activella dosage: 1mg/0.5mg. During the same period patient was treated with ESTRACE (1 Mg) (View Estrace Review and Estrace Label ), PROVERA (5 Mg) (View Provera Review and Provera Label ), PREMPRO (0.625/2,5mg; 0.625/2.5mg) (View Prempro Review and Prempro Label ), ORTHO PREFEST(ESTRADIOL, NORGESTIMATE) (View Ortho-prefest(estradiol, Norgestimate) Review and Ortho-prefest(estradiol, Norgestimate) Label ), ORTHO NOVUM 0.5/50 21 TAB (View Ortho Novum 0.5/50 21 Tab Review and Ortho Novum 0.5/50 21 Tab Label ), ACTIFED /00005601/ (PSUEDOEPHEDRINE HYDROCHLORIDE, TRIPOLIDINE HYDROCH (View Actifed /00005601/ (psuedoephedrine Hydrochloride, Tripolidine Hydroch Review and Actifed /00005601/ (psuedoephedrine Hydrochloride, Tripolidine Hydroch Label ).

6215167-2 | Breast Cancer
Adverse event was reported on May 08, 2009 by a Female patient taking Activella (View Usage) (Dosage: Oral) was diagnosed with hot flush and. Location: UNITED STATES , 64 years of age, weighting 164.9 lb, Patient had the following side effects: breast cancer (What is breast cancer?). During the same period patient was treated with PREMPRO (Oral) (View Prempro Review and Prempro Label ), ESTRATEST (View Estratest Review and Estratest Label ), PROVERA (Oral) (View Provera Review and Provera Label ), PREMARIN (Oral) (View Premarin Review and Premarin Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ).

6215166-0 | Breast Cancer
on Nov 25, 2008 Female patient from UNITED STATES , 61 years of age, weighting 145.1 lb, was diagnosed with menopausal symptoms and was treated with Activella (View Usage). After Activella was administered, patient had the following side effects: breast cancer (What is breast cancer?). Activella dosage: . During the same period patient was treated with PREMPRO (View Prempro Review and Prempro Label ), PREMARIN (1.25 Mg) (View Premarin Review and Premarin Label ), PROVERA (2.5 Mg) (View Provera Review and Provera Label ), ESTRATEST (View Estratest Review and Estratest Label ), ENOVID E (MESTRANOL, NORETYNODREL S) (View Enovid-e (mestranol, Noretynodrel-s) Review and Enovid-e (mestranol, Noretynodrel-s) Label ), PROZAC (View Prozac Review and Prozac Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), VIOXX (View Vioxx Review and Vioxx Label ).

6215164-7 | Muscle Spasms
on Nov 21, 2008 Female patient from UNITED STATES , 54 years of age, was diagnosed with hot flush and was treated with Activella (View Usage). Patient experienced the following unwanted or unexpected effects: muscle spasms. Activella dosage: 1 Tab, Qd, Oral.

6215153-2 | Breast Cancer
Patient was taking Activella (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?) on Oct 31, 2008 from UNITED STATES Additional patient health information: Female patient , 59 years of age, weighting 153.0 lb, was diagnosed with hot flush, menorrhagia and. Activella dosage: . During the same period patient was treated with PREMPRO (5 Mg) (View Prempro Review and Prempro Label ), PREMARIN (0.625 Mg) (View Premarin Review and Premarin Label ), ORTHO PREFEST(ESTRADIOL, NORGESTIMATE) (View Ortho-prefest(estradiol, Norgestimate) Review and Ortho-prefest(estradiol, Norgestimate) Label ), ACTOS /01460201/(PIOGLITAZONE) (View Actos /01460201/(pioglitazone) Review and Actos /01460201/(pioglitazone) Label ).